A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Key Inclusion Criteria:
Key Exclusion Criteria:
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
San Francisco, California 94143, United States
Torrance, California 90502, United States
Torrance, California, United States
Bradenton, Florida 34209, United States
Kansas City, Kansas 66160, United States
Allentown, Pennsylvania 18102, United States
QLD, 4029, Australia
Talinn, Estonia
Cedex 9, Auvergne-Rhône-Alpes 38043, France
Marseille, Provence-Alpes-Côte d'Azur Region, France
Paris, Île-de-France Region 75651, France
Heidelberg, Baden-Wurttemberg, Germany
Cologne, North Rhine-Westphalia 50937, Germany
Essen, North Rhine-Westphalia 45122, Germany
Hamburg, Germany
Wüerzburg, Germany
Milan, 20127, Italy
Bialystok, Podlaskie Voivodeship, Poland
Hampshire, England, United Kingdom